GEP-based approaches have also been applied to identify MYC-driven subgroups of DLBCL, including the double-hit signature and molecular high-grade (MHG), both of which partially overlap with double- and triple-hit lymphomas [7,8]. The gene discussed is MYC; the disease is lymphoma.